Anxiolytic effects of Dolichandrone falcata Seem., Bignoniaceae, stem-bark in elevated plus maze and marble burying test on mice;Efeitos ansiolíticos das cascas de Dolichandrone falcata Seem., Bignoniaceae, em teste do labirinto em cruz elevada e teste de esconder esferas, em camundongos

Revista Brasileira de Farmacognosia

Volumn 20, Issue 5, 2010, Pages 773-780

  Badgujar Vishal, B ^a   Surana Sanjay, J ^a  

^a R C PATEL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH   (India)

Author keywords

Anxiolytic effect; Benzodiazepine; Bignoniaceae; Diazepam; Dolichandrone falcata; Elevated plus maze; Fluoxetine; Marble burying

Indexed keywords

ACETIC ACID ETHYL ESTER; ANXIOLYTIC AGENT; DOLICHANDRONE FALCATA EXTRACT; METHANOL; PLANT EXTRACT; UNCLASSIFIED DRUG;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ARTICLE; BARK; DOLICHANDRONE FALCATA; DOSE RESPONSE; DRUG ISOLATION; DRUG SCREENING; DRUG SYNTHESIS; ELEVATED PLUS MAZE TEST; EXPERIMENTAL TEST; FEMALE; MALE; MARBLE BURYING TEST; MEDICINAL PLANT; MOUSE; NONHUMAN; PHYTOCHEMISTRY; PLANT STEM; THIN LAYER CHROMATOGRAPHY; TOXICITY TESTING; TRANQUILIZING ACTIVITY;

EID: 78650362444     PISSN: 0102695X     EISSN: None     Source Type: Journal    
DOI: 10.1590/S0102-695X2010005000028     Document Type: Article

References (35)

1. Asia Pacific Medicinal Plant Database Broader topics Medicinal Plant Database. Available at: http://219.93.41.233/wapi/mctweb.dll/getObject?MID=MEDICINALPLANT&Ob jID=1841. Accessed on 14 October 2009.
2. Atack JR 2003. Anxioselective compounds acting at the GABA (A) receptor benzodiazepine binding site. CNS Neurol Disord Drug Targets 2: 213-232.
3. Bhattacharya SK, Mitra SK 1991. Anxiolytic activity of Panax ginseng roots: an experimental study. J Ethnopharmacol 34: 87-92.
4. Borsini F, Podhorna J, Marazziti D 2002. Do animal models of anxiety predict anxiolytic-like effects of antidepressants? Psychopharmacology (Berl) 163: 121-141.
5. Broekkamp CL, Rijk HW, Joly-Gelouin D, Lloyd KL 1986. Major tranquillizers can be distinguished from minor tranquillizers on the basis of effects on marble burying and swim-induced grooming in mice. Eur J Pharmacol 126: 223-229.
6. Cha HY, Park JH, Hong JT, Yoo HS, Song S, Hwang BY 2005. Anxiolytic-like effects of ginsenosides on the elevated plus-maze model in mice. Biol Pharm Bull 28: 1621-1625.
7. Costa E, Guidotti A 1996. Benzodiazepines on trial: a research strategy for their rehabilitation. Trends Pharmacol Sci 17: 192-200.
8. Degroot A, Nomikos G 2005. Fluoxetine disrupts the integration of anxiety and aversive memories. Neuropsychopharmacology 30: 391-400.
9. Espejo E 1997. Structure of the mouse behavior on the elevated plus-maze test of anxiety. Behav Brain Res 86: 105-112.
10. Friede M, Freudenstein J 2002. Antidepressant and anxiolytic effect of St. John's wort extract ZE-117. Eur Psychiatr 17(Suppl. 1): 96-96.
11. Gokhale SB, Purohit AP, Kokate CK 2008. A Textbook of Pharmacognosy. Nirali Prakashan, Pune India, p. 201.
12. Griffiths RR, Ator NA, Roache JD, Lamb RJ 1987. Abuse liability of triazolam: experimental measurements in animals and humans. Psychopharmacol Ser 3: 83-87.
13. Jordan AD, Kordik CP, Reitz AB, Sanfillipo PJ 1996. Novel anxiolytic agents- 1994 to present. Expert Opin Ther Patents 6: 1047-1060.
14. Kaplan HI, Sadock BJ 2005. Comprehensive Textbook of Psychiatry, 8th ed. New York: Lippincot Williams and Wilkins.
15. Kennett GA, Trail B, Bright F 1998. Anxiolytic-like actions of BW723C86 in the rat Vogel conflict test are 5-HT2B receptor mediated. Neuropharmacology 37: 1603-1610.
16. Lader M, Morton S 1991. Benzodiazepine problems. Br J Addict 86: 823-828.
17. Lister RG 1987. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berl) 92: 180-185.
18. Lleana S, Oana RP, Loana S 2004. The study of separation of active components from the propolis extract. Annals West Uni Timi Series Chem 15: 9-14.
19. Marder M, Paladini AC 2002. GABAA-receptor ligands of flavonoid structure. Curr Top Med Chem 2: 853-867.
20. Nazar M, Jessa M, Plaznik A 1997. Benzodiazepine-GABAA receptor complex ligands in two models of anxiety. J Neural Transm 104: 733-746.
21. Njung'e K, Handley SL 1991. Evaluation of marble-burying behavior as a model of anxiety. Pharmacol Biochem Behav 38: 63-67.
22. OECD 2006. Guidelines for Testing of Chemicals. Revised draft Guidelines 425: Acute oral toxicity-up and down method, Revised document.
23. Paladini C, Marder M, Viola H, Wolfman C, Wasowski C, Medina JH 1999. Flavonoids and the central nervous system: from forgotten factors to potent anxiolytic compounds. J Pharmacy Pharmacol 51: 519-526.
24. Park JH, Cha HY, Seo JJ, Hong JT, Han K, Oh KW 2005. Anxiolytic-like effects of ginseng in the elevated plusmaze model: comparison of red ginseng and sun ginseng. Prog Neuropsychopharmacol Biol Psychiatry 29: 895-900.
25. Patil DA 2003. Flora of Dhule and Nandurbar districts (Maharashtra). Bishen Singh Mahendra Pal Singh Publishers and Distributors of Scientific Books. Dehradun. p. 440.
26. Pellow S, Chopin P, File SE, Briley M 1985. Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J Neurosci Methods 14: 149-167.
27. Shin JS, Kim KS, Kim MB, Jeong IJH, Kim BK 1999. Synthesis and hypoglycemic effects of chrysin derivatives. Bioorg Med Chem 9: 869-874.
28. Sinaphet B, Noiarsa P, Kanchanapoom T 2006. Dolichandroside, a new phenolic triglycoside from D. serrulata. J Nat Med 60: 251-254.
29. Subramanian SS, Nagarajan S, Sulochana N 1972. Chrysin-7-rutinoside from the leaves of Dolichandrone falcata. Phytochemistry 11: 438-439.
30. Trabera J, Glaser T 1987. 5-HT1A receptor-related anxiolytics. Trends Pharmacol Sci 8: 432-437.
31. Vidyasagar GM, Prashantkumar P 2007. Traditional herbal remedies for gynecological disorders in women of Bidar district, Karnataka, India. Fitoterapia 78: 48-51.
32. Wang F, Shing M, Huen Y, Tsang SY, Xue H 2005. Neuroactive flavonoids interacting with GABA-A receptor complex. CNS Neurol Disord Drug Targets 4: 575-585.
33. Wolfman C, Viola H, Marder M, Wasowski C, Ardenghi P, Izquierdo I, Paladini AC, Medina JH 1996. Anxioselective properties of 6,3'-dinitroflavone, a high-affinity benzodiazepine receptor ligand. Eur J Pharmacol 318: 23-30.
34. Wolfman C, Viola H, Paladini A, Dajas F, Medina JH 1994. Possible anxiolytic effects of chrysin, a central benzodiazepine receptor ligand isolated from Passiflora coerulea. Pharmacol Biochem Behav 47: 1-4.
35. Yamada K, Wada E, Yamano M, Sun YJ, Ohara-Imaizumi M, Nagamatsu S 2002. Decreased marble burying behavior in female mice lacking neuromedin-B (NMB-R) implies the involvement of NMB/NMB-R in 5-HT neuron function. Brain Res 942: 71-78.